Nanos
Membership Organizations · New Jersey, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
310 Bergen Blvd, Fairview, New Jersey, 0...Phone Number
(952) 646-2037Website
www.nanosweb.orgRevenue
$46.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Nanos
NANOS is a professional organization comprising over 900 trained ophthalmologists and neurologists focused on advancing neuro-ophthalmology through education, research, and community engagement. The society promotes inclusive excellence in the care of patients with neuro-ophthalmic diseases by supporting equitable education and clinical practice. NANOS offers various initiatives, including an annual scientific meeting, a journal, and support for emerging clinicians and researchers. Their intended clients include students, clinicians, and researchers in the field of neuro-ophthalmology.Explore more
Nanos Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Nanos your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Nanos has recently received funding, and reach out quickly before it becomes old news!
Click to see if Nanos had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Nanos has new funding data
Earning: See what the market has to say on Nanos recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Nanos launches new products
Check out if Nanos is spiking on competitors!
Website visits: Recent activity has been detected on your website
Nanos, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Nanos
Recommended Actions
Reach out to Masked Content who joined Nanos as Masked Content
Find 3 more new buyers
Compare Similar Companies to Nanos
Compare insights from companies similar to Nanos, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Nanos is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
Nanos is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about Nanos.
Nanos Tech Stack
A closer look at the technologies used by Nanos
Nanos News & Media
Oculis to Present at Upcoming North American Neuro-Ophthalmology Society Annual Meeting
ZUG, Switzerland, 16 March, 2026 -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (Oculis), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in ophthalmology and neuro-ophthalmology, today announced the presentation of the ACUITY Phase 2 data with Privosegtor at the North American Neuro-Ophthalmology Society (NANOS) 52nd Annual Meeting.Lirum Therapeutics Announces Debut of LX-101 Results in Thyroid Eye Disease, Selected for Presentation at the 2025 NANOS Annual Meeting
New York, NY, March 17, 2025 (GLOBE NEWSWIRE) -- Lirum Therapeutics, Inc. (“Lirum”), an innovative clinical-stage biopharmaceutical company focused on the treatment of debilitating diseases, announced today that its first data on LX-101 in Thyroid Eye Disease (TED) have been selected for presentation at the 51st Annual Meeting of the North American Neuro-Ophthalmology Society (NANOS), March 15-20 in Tucson, Arizona.New Survey Assessment Finds Debilitating Impact of Thyroid Eye Disease (TED) on Quality of Life Continues Well Beyond Acute Disease into Chronic Phase
DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics announced results of a new Thyroid Eye Disease (TED) quality of life assessment presented at the NANOS Annual Meeting.GenSight Biologics Announces Presentation of Bilateral Visual Recovery From GS010 (LUMEVOQ™) Phase III Trials at the 46th Annual Meeting of NANOS
PARIS--(BUSINESS WIRE)--Regulatory News: GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on discovering and developing innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, announced today that the bilateral visual recovery observed with GS010 (LUMEVOQ™) in the REVERSE and RESCUE Phase III trials will be presented and discussed at the 46th Annual Meeting of the North American N
Read more news
Top Membership Organizations Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nanos
Sign Up For FreeTo access detailed company insights
NANOS is a professional organization comprising over 900 trained ophthalmologists and neurologists focused on advancing neuro-ophthalmology through education, research, and community engagement. The society promotes inclusive excellence in the care of patients with neuro-ophthalmic diseases by supporting equitable education and clinical practice. N... Read More
